Skip to Main Content


  • Judith Lichtman

    Department Chair and Professor of Epidemiology (Chronic Diseases); Co-director, Center for Neuroepidemiology and Clinical Neurological Research

    Research Interests
    Epidemiology; Heart Diseases; Quality of Health Care; Research; Stroke

    Judith H. Lichtman, PhD, MPH is an Associate Professor in the Department of Chronic Disease Epidemiology at the Yale School of Public Health in New Haven, CT. She completed her undergraduate degree at the University of Rochester in Rochester, NY, and received her Master of Public Health degree and PhD in Epidemiology at Yale University. Dr. Lichtman has been actively involved in regional and national studies of cardiovascular and stroke outcomes. She has served on several national committees including the AHA Patient Education System Task Force, the AHA Peer Review Evaluation Design Task Force, the AHA Stroke and Epidemiology Councils, and the AHA Quality of Care and Outcomes Research Expert Panel. She has been a member of the Program Committee for the American Heart Association Conference on Cardiovascular Disease Epidemiology and Prevention, the co-chair for two National American Heart Association Writing Committees, and was recently appointed as a member of the American Stroke Association Advisory Committee, as well as the Quality Improvement Working group for the AHA Get With the Guidelines Program. Dr. Lichtman has been the Principal Investigator for projects funded by the Goddess Foundation, Fannie E. Rippel Foundation, AHA, CDC, NIA, AHRQ, NHLBI, and NINDS. Dr. Lichtman’s research focuses on examining the epidemiology of stroke and heart disease using longitudinal databases and prospective observational studies.

  • Michael B. Bracken

    Susan Dwight Bliss Professor Emeritus and Senior Research Scientist

    Research Interests
    Epidemiology; Gynecology; Neurology; Pediatrics; Perinatal Care; Evidence-Based Medicine

    Dr. Michael Bracken is the Susan Dwight Bliss Professor Emeritus of Epidemiology, Senior Research Scientist in Epidemiology, and formerly Professor of Obstetrics and Gynecology, Reproductive Science and Neurology, a former Head of Chronic Disease Epidemiology at Yale University and former Vice Chairman (Deputy Dean) of the Yale School of Public Health where he has studied and taught for the last 50 years. He is a sometime Research Fellow in Green Templeton College, Oxford University. Professor Bracken has published some 400 articles in the scientific literature and has authored three books: Perinatal Epidemiology (1984) and Effective Care of the Newborn Infant (with J.C. Sinclair, 1992) both published by Oxford University Press. In 2006 this last book, which introduced the concepts of meta-analysis into neonatology, was named by the British Medical Journal as one of the most influential books in evidence-based medicine and was instrumental in assisting the foundation of the international Cochrane Collaboration. His new book: Risk, Chance and Causation: Investigating the Origins and Treatment of Disease was published by Yale University Press in 2013. He is the founding (in 1979) Director of the Yale Perinatal Epidemiology Unit and Co-Director of its successor, the Yale Center for Perinatal, Pediatric and Environmental Epidemiology. Professor Bracken has taught courses in evidence-based medicine and health care, pharmaco-epidemiology, perinatal epidemiology and general epidemiology at Yale for many years. He has directed numerous epidemiological investigations, almost all of which were funded (over $50 million in total) by the United States National Institutes of Health (NIH). He has served on numerous study sections and committees of the NIH including the Council of the National Institute of Deafness and Communicative Disorders. He chaired the first Congress of Epidemiology in 2001 and the first international colloquium on genome–wide association studies in 2006. He consults for many international corporations and agencies including the World Health Organization and he has served as the elected President of two major epidemiological organizations: the American College of Epidemiology and the Society for Epidemiologic Research. Professor Bracken is the 2013 recipient of the Lilienfeld Award from the American College of Epidemiology, a 2015 D.Sc honoris causa from the University of Gloucester in the UK, and the 2016 Gordon Lecture award from the National Institutes of Health.

  • Mayur M. Desai

    Associate Professor of Epidemiology (Chronic Diseases); Associate Dean for Diversity, Equity, and Inclusion, YSPH; Director, Advanced Professional MPH Program; Core Faculty, National Clinician Scholars Program

    Research Interests
    Mental Disorders; Cardiovascular Diseases; Epidemiologic Methods; Health Services Research; Public Health; Quality of Health Care; Veterans; Global Health; Emigrants and Immigrants

    Mayur M. Desai, PhD, MPH, is an Associate Professor of Epidemiology at the Yale School of Public Health, where he directs the one-year Advanced Professional MPH Program and teaches courses on epidemiologic research methods and data analysis. Professor Desai received both his MPH in health policy and his PhD in epidemiology from Yale University. He then served for two years as an Epidemic Intelligence Service (EIS) Officer at CDC’s National Center for Health Statistics, before returning to New Haven to join the Yale faculty. As a core faculty member in Yale’s National Clinician Scholars Program, he is responsible for coordinating the “Clinical and Health Services Research Methods” course and teaching the quantitative methods portion of the curriculum. Professor Desai’s research interests focus on:

    1. improving the quality and outcomes of medical care in complex and vulnerable populations, including persons with mental disorders, veterans, immigrants, and the elderly; and
    2. workforce issues in public health and medicine.

    At the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE), Professor Desai is collaborating with a multidisciplinary team of investigators, under contract with the Centers for Medicare & Medicaid Services, to develop statistical models that are used to measure and publicly report hospital clinical outcomes using Medicare administrative data.

  • Andrew Thomas DeWan

    Associate Professor of Epidemiology (Chronic Diseases); Co-Director, Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Chronic Disease Epidemiology

    Research Interests
    Asthma; Chronic Disease; Epidemiology; Genetics; Norway; Pre-Eclampsia; Sepsis

    Andrew DeWan is currently an Associate Professor in the Department of Chronic Disease Epidemiology at the Yale School of Public Health where in 2012 he was selected for the Distinguished Student Mentor Award by the student body. He earned his B.S. from Brandeis University, MPH from the University of Minnesota and his PhD from Rockefeller University. He is an Editorial Board Member for the journal PLoS ONE, Case Reports in Genetics and is review editor for Frontiers in Genetics.

    Professor DeWan studies how variation in the human genome contributes to complex human diseases. Using high-throughput technologies, he conducts genome-wide association studies to map disease susceptibility loci. His work also emphasizes the development of methods that improve the way in which this information is interpreted and utilized by disease researchers. He is also interested in the role that the interaction between genetic and environmental factors plays on disease susceptibility. His work mapping disease genes has led to the discovery of susceptibility loci for age-related macular degeneration, non-syndromic hearing loss, renal function and myopia.

  • Leah Ferrucci

    Assistant Professor of Epidemiology (Chronic Diseases)

    Research Interests
    Breast Neoplasms; Chronic Disease; Diet; Epidemiology; Public Health; Skin Neoplasms; Tanning; Colorectal Neoplasms; Survivors; Metabolomics

    Leah M. Ferrucci, PhD, MPH is an assistant professor at the Yale School of Public Health. Dr. Ferrucci earned her BA from the University of Pennsylvania and her MPH in the Social and Behavioral Sciences at the Yale School of Public Health. She received a PhD in nutritional cancer epidemiology through a joint training program with Yale University and the National Cancer Institute. Throughout her career, Dr. Ferrucci has focused on modifiable cancer risk factors, including nutrition and ultraviolet radiation related exposures, as well as cancer survivorship. As a post-doctoral fellow, Dr. Ferrucci was supported by an Individual National Research Service Award from the National Cancer Institute to study the etiology of early-onset basal cell carcinoma, including indoor tanning, alcohol intake, tea, coffee, and caffeine. Based on this etiologic research, Dr. Ferrucci is working to translate these findings into behavioral interventions to reduce indoor tanning in young women and adolescent girls. Her current research in skin cancer is supported by a Mentored Research Scholar Grant from the American Cancer Society. Dr. Ferrucci is also studying diet quality and food insecurity among female cancer survivors in New Haven and conducting research on metabolomics and the microbiome in the context of weight loss and lifestyle intervention trials for breast cancer survivors.

  • Nicola Hawley

    Assistant Professor of Epidemiology (Chronic Diseases)

    Research Interests
    Diabetes Mellitus; Maternal Health Services; Maternal-Child Health Centers; Obesity; Pregnancy; Prenatal Care; Global Health; Samoa; American Samoa

    Nicola Hawley is an Assistant Professor of Epidemiology (Chronic Diseases) at the Yale School of Public Health. Her research focuses broadly on: (1) understanding how maternal and child health are impacted by rising levels of obesity and diabetes in developing countries, (2) determining how the delivery of healthcare impacts the identification and treatment of these diseases during the perinatal period, and (3) developing interventions focused on pregnancy and early infancy to prevent the intergenerational transmission of chronic disease. She has ongoing projects and collaborations in American Samoa, Samoa, South Africa, and the US. Dr. Hawley earned her PhD in Human Biology from the Center for Global Health and Human Development at Loughborough University, UK.

  • Josephine Hoh

    Associate Professor of Epidemiology (Chronic Diseases) and of Ophthalmology and Visual Science

    Research Interests
    Environmental Exposure; Environmental Health; Ophthalmology

    Josephine Hoh, associate professor in chronic disease epidemiology and of ophthalmology and visual science, is currently involved in interdisciplinary research to elucidate disease pathophysiology, including how the genetic factors can actually lead individuals who carrying the risk variants to be ill at one point in life, what the environmental exposures are, and how they can influence an individual’s chance of contracting the disease.

    Dr. Hoh was trained in mathematics in Taiwan and theoretical statistics and probability under the supervision of Professor Zhiliang Ying and the late Professor Herbert Robbins at Rutgers University.

    As a research assistant professor at Rockefeller University she worked with Jurg Ott on linkage analysis for genetic factors of human disease and developed her expertise in biology. Two of the computational methods and tools they developed, SUMSTAT and p53MH, continue to be widely used. SUMSTAT can efficiently and effectively identify disease associated genetic variants, while p53MH and its extension can identify the DNA response elements of a tumor suppressor p53 as well as other transcription factors.

    Now an associate professor at the Yale School of Public Health, Hoh focuses on developing new approaches to discover the genetic risks for more common diseases which usually have complex influences from both genetics and environmental exposures. Collaborating with national and international groups (Drs. Emily Chew and Rick Ferris at the National Eye Institute and Dr. Calvin Pang of Hong Kong University) her work on age-related macular degeneration (AMD), the most common cause of blindness in developed world, led to the first successful application of the genome-wide association study (GWAS) approach and was published widely. By employing GWAS, the Hoh lab has also investigated other complex traits including carcinoid cancer, scleroderma, asthma, longevity, among others.

  • Melinda Irwin

    Associate Dean of Research and Professor of Epidemiology (Chronic Diseases); Associate Cancer Center Director (Population Sciences), Yale Cancer Center; Co-Leader, Cancer Prevention and Control, Yale Cancer Center; Deputy Director (Public Health), Yale Center for Clinical Investigation

    Research Interests
    Breast Neoplasms; Neoplasms by Histologic Type; Obesity; Ovarian Neoplasms; Weight Loss; Exercise

    Melinda L. Irwin, PhD, MPH is Associate Dean of Research and Professor of Epidemiology at the Yale School of Public Health, Associate Director (Population Sciences) in the Yale Cancer Center, Co-Program Leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, and Deputy Director (Public Health) in the Yale Center for Clinical Investigation. Nationally, Dr. Irwin co-leads the SWOG Cancer Research Network Cancer Survivorship Committee.Dr. Irwin is a prominent leader in the field of lifestyle factors and cancer prevention and control. Her research over the past 20 years has focused on randomized trials of exercise and weight loss on biological markers, treatment side effects and quality of life in cancer patients and survivors. She has received funding from the NIH, ACS, American Institute for Cancer Research, Komen for the Cure, and Livestrong Foundation.She is currently examining the impact of nutrition and exercise on improving chemotherapy completion rate, endocrine therapy adherence, biomarkers, body composition and quality of life in an NCI-funded R01 trial in women beginning chemotherapy for breast cancer. Dr. Irwin is committed to training the next generation of scientists, and is currently leading an NCI R25-funded international effort focused on training early career investigators in energy balance and cancer research entitled the Transdisciplinary Research on Energetics and Cancer (TREC) Training Program. At Yale, Dr. Irwin has advised, mentored and trained over 100 trainees on public health related studies. Dr. Irwin also serves on various national advisory committees to develop consensus statements on physical activity, diet, weight and cancer prevention and control.

  • Community Mentor

    Dr. Kennedy is the Director of Health for the City of New Haven. Trained in preventive medicine, he received all his higher education at Yale. Hehas broad expertise in community-based approaches aimed at improving the health of vulnerable populations. As Health Director, he has worked collaboratively with multiple stakeholder groups from the public, private and nonprofit sectors to promote health and wellness. He has given a number of lectures/presentations to students, medical professionals, community groups, and policy makers. In addition, he has practiced in urgent care, occupational medicine, and general practice clinics, including both pediatric and adult patients. Finally, Dr. Kennedy has published papers in heart disease and stroke, health disparities, and tobacco control.
  • Xiaomei Ma

    Professor of Epidemiology (Chronic Diseases); Co-Leader, Cancer Prevention and Control

    Research Interests
    Chronic Disease; Epidemiology; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms

    Dr. Ma is Professor of Epidemiology at the Yale School of Public Health, and Co-Leader of the Cancer Prevention and Control Research Program at the Yale Comprehensive Cancer Center, Yale School of Medicine. She studies the etiology and health outcomes of different types of cancer, with a focus on pediatric cancer and malignancies of the hematopoietic system (e.g., leukemia, lymphoma, and myeloproliferative neoplasms). Her research has addressed the impact of immunological factors, chemical exposures, and genetic characteristics on the risk of cancer. In addition, she has assessed the patterns of care and cost implications of cancer screening and treatment in older adults.

  • Harvey Risch

    Professor of Epidemiology (Chronic Diseases)

    Research Interests
    Esophageal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Polymorphism, Genetic; Gonadal Steroid Hormones; Stomach Neoplasms; Helicobacter pylori; Molecular Epidemiology; Germ-Line Mutation; Host-Pathogen Interactions

    Dr. Harvey Risch is Professor of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine. Dr. Risch received his MD degree from the University of California San Diego and PhD from the University of Chicago. After serving as a postdoctoral fellow in epidemiology at the University of Washington, Dr. Risch was a faculty member in epidemiology and biostatistics at the University of Toronto before coming to Yale. Dr. Risch's research interests are in the areas of cancer etiology, prevention and early diagnosis, and in epidemiologic methods. He is especially interested in the effects of reproductive factors, diet, genetic predisposition, histopathologic factors, occupational/environmental/medication exposures, infection and immune functioning in cancer etiology. His major research projects have included studies of ovarian cancer, pancreas cancer, lung cancer, bladder cancer, esophageal and stomach cancer, and of cancers related to usage of oral contraceptives and noncontraceptive estrogens. Dr. Risch is Associate Editor of the Journal of the National Cancer Institute, Editor of the International Journal of Cancer, and Member of the Board of Editors, the American Journal of Epidemiology.  Dr. Risch has an h-index of 83 and is a Member of the Connecticut Academy of Sciences and Engineering.

  • Shi-Yi Wang

    Associate Professor of Epidemiology (Chronic Diseases)

    Dr. Wang is an Associate Professor at the Yale School of Public Health, faculty member of Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, and faculty member of Public Health Modeling Concentration, Yale School of Public Health. His primary interests focus on outcomes research and decision science. He is interested in combining systematic literature reviews, secondary data analyses, and simulation modeling to examine issues that are critical to clinicians and policy makers’ decision making. He has been working on several breast cancer projects, including an evaluation of preoperative breast MRI, development of an individualized decision aid to help radiotherapy decision-making, and assessment of sentinel lymph node biopsy for patients with ductal carcinoma in situ. He is also evaluating end-of-life care quality. He serves as the primary investigator or co-investigator in several projects (funded by Yale Cancer Center, AHRQ, NCI, ACS, and PCORI).

Research Scientists

  • Brenda Cartmel

    Senior Research Scientist in and Lecturer in Epidemiology (Chronic Diseases)

    Research Interests
    Carcinoma; Chronic Disease; Epidemiology; Nutrition Disorders; Ovarian Neoplasms; Stress, Psychological; Tanning; Disease-Free Survival; Nutritional Sciences

    Dr. Cartmel's primary research interests are in the area of cancer prevention and cancer survivorship. Dr. Cartmel is Co-Leader for the 'Personalized Intervention Program: Tobacco Treatment for Lung Cancer Screening Patients (PIP), one of four projects which are part of the Yale Lung SPORE (PI: Dr. Roy Herbst).  In addition to this study, Dr. Cartmel is involved in several diet and exercise intervention studies in cancer survivors (Melinda Irwin Ph.D. and Tara Sanft, M.D. PIs).  She is also participating in a nationwide longitudinal quality of life study in cancer survivors in which she is studying communication of health information to long-term cancer survivors. Other interests include the use of a novel noninvasive assessment method of skin carotenoids and skin cancer etiology and prevention, including work on tanning addiction.


  • Shahidul Islam

    Associate Research Scientist in Epidemiology (Chronic Diseases)

    Research interests

    Neurogenesis, Neural stem cells, Axon guidance, Neurodevelopment disorders and neurodegenerative diseases such as Microcephaly, Agenesis of corpus callosum, Amytrophic lateral sclerosis (ALS), Frontotemporal dementia (FTD), Alzheimer's disease and Parkinson's disease.

  • Beth Jones

    Research Scientist in and Lecturer in Epidemiology (Chronic Diseases); Assistant Cancer Center Director for Diversity and Health Equity, Yale Cancer Center; Director, Smilow Screening & Prevention Program

    Research Interests
    Breast Neoplasms; Neoplasms; Social Class; Socioeconomic Factors; Epidemiologic Factors; Health Care Quality, Access, and Evaluation; Minority Health; Health Status Disparities; Healthcare Disparities; Social Determinants of Health; Health Care

    Dr. Jones is a cancer epidemiologist whose work and teaching focus is on health disparities. Her research is focused on racial/ethnic differences in cancer screening and cancer outcomes. Current work has focused on the Hispanic/Latino population with studies of predictors of mammography screening and other health behaviors, breast density, and colorectal cancer screening in Hispanic/Latinas living in the Northeast, US. Using a multidisciplinary approach, she has evaluated the role(s) of tumor characteristics, selected genetic alterations and genetic polymorphisms, as well as social class, medical care, and psychosocial factors, in explaining differences cancer stage at diagnosis and survival between African Americans and Whites in breast, prostate, and colorectal cancer. Other work has identified important African American/White differences in mammography screening and screening outcomes.

  • Erica C Leifheit

    Research Scientist in Epidemiology (Chronic Diseases)

    Research Interests
    Cardiovascular Diseases; Quality of Health Care; Quality of Life; Stroke

    Erica Leifheit is a Research Scientist in the Department of Chronic Disease Epidemiology at Yale School of Public Health. Her research interests are in psychosocial, cardiovascular, and cerebrovascular epidemiology and outcomes. Dr. Leifheit’s earlier work focused on the relationship of psychosocial factors, such as social support, depression, and stress, to patient-centered outcomes and adherence after acute myocardial infarction. Her current work centers on outcomes after stroke, using national healthcare claims data to better understand patterns in stroke care delivery and outcomes across hospitals and geographic regions. She is also involved in a number of projects that use Medicare administrative data to enhance the surveillance of patient outcomes for clinical trials and prospective registries. Dr. Leifheit received her PhD in epidemiology and public health from Yale University. 

  • Jessica Lewis

    Associate Research Scientist in Epidemiology (Chronic Diseases); Project Director, Expect With Me

    Research Interests
    Behavior and Behavior Mechanisms; Social Sciences; Health Care Quality, Access, and Evaluation

    Jessica Lewis is the Deputy Director of Pregnancy Research at Yale School of Public Health and Project Director for Expect With Me. She has directed research projects on women’s reproductive health at Yale for more than 20 years. She has served as the Project Director for several randomized controlled trials and dissemination studies of group prenatal care. Her research investigates the interplay of complex biomedical, behavioral, social and psychological factors that influence individual and family health. She uses this lens to examine challenges faced by those often marginalized by the health care system and by society. Ms. Lewis has expertise in running large, scientifically rigorous clinical trials in a community setting with methodological rigor and cultural sensitivity. Additionally, she has expertise in the clinical implementation of group prenatal care models. She currently serves as the Project Director for Expect With Me, a new model of group prenatal care that incorporates a strong IT infrastructure and a series of behavioral interventions to improve maternal and child health outcomes and long term family health. She is a Doctoral Candidate in Social Welfare at the City University of New York (CUNY) Graduate Center. Her dissertation work focuses on intimate partner violence and sexual risk among pregnant and parenting adolescent couples.

  • Lingeng Lu

    Research Scientist in Epidemiology (Chronic Diseases)

    Research Interests
    Aging; Breast Neoplasms; HIV; Immunologic Factors; Insulin-Like Growth Factor II; Ovarian Neoplasms; Pancreatic Neoplasms; Polymorphism, Genetic; Helicobacter pylori; Endometrial Neoplasms; Molecular Epidemiology; Reproductive Medicine; DNA Methylation; Metabolic Syndrome; MicroRNAs; RNA, Long Noncoding

    Dr. Lu is currently a Research Scientist  in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. Dr. Lu’s research focuses on determining the role of genetic, epigenetic and environmental factors in the susceptibility and clinical outcome of chronic diseases, particularly human cancer (gynecologic and gastrointestinal cancer), metabolic syndrome, HIV/ADIS, mental and reproductive health. He is now leading the Molecular Cancer Epidemiology Laboratory and Shared Resource of the Yale Cancer Center and YSPH, and develops molecular biology tools and technologies, providing critical laboratory supports for studies by colleagues. His research also involves data mining, bioinformatics and pathway analyses, DNA/RNA secondary structure. Using next-generation small RNA-seq technologies, he recently explored the associations of miRNAs in circulating cell-secreted exosomes and HIV-associated neurological disorders. His research has addressed the prognostic and predictive values of genetic, epigenetic (non-coding RNAs and DNA methylation), growth factors and immunological factors in several human malignancies, and the effect of the biological and environmental factors on the risk of several chronic diseases.

  • Alysa Pomer

    Associate Research Scientist in Epidemiology (Chronic Diseases)

    Research Interests
    Disasters; Menarche; Vanuatu; Obesity; Rural Health; Global Health; Samoa; Reproductive Health

    Alysa Pomer is an Associate Research Scientist in the Department of Chronic Disease Epidemiology in the Yale School of Public Health. Her research focuses on health in Pacific Island nations. She is particularly interested in adolescent and reproductive health during population health transition. Dr. Pomer's previous work has included research on secular trends in menarche and psychosocial stress after natural disasters. Her current research investigates the development of chronic disease in the Pacific Island nation of Samoa. Dr. Pomer earned her PhD in Biological Anthropology from Binghamton University, in Binghamton, NY.

  • Sakinah Carter Suttiratana

    Associate Research Scientist

    Dr. Suttiratana is a Sociologist of Health and Illness whose interests include various sociocultural influences on health. She currently serves as Coordinator for the Yale Cancer Disparities Firewall Project, a partnership between the Yale School of Public Health and the Yale Cancer Center. The project aims to improve prevention and screening behaviors among New Haven residents while building health promotion infrastructure to benefit local cancer prevention and control. Other research includes a study of diet and physical activity habit formation among transnational, immigrants from the Caribbean and using mixed methods to improve care and devices for youth with Type 1 diabetes mellitus and their families. 

    Dr. Suttiratana’s interests coalesce around considerations of social science insights to strengthen the reach and impact of public health messages and interventions. In this vein, she has contributed to various translational and community based research and implementation projects among diverse U.S. and international populations. Dr. Suttiratana has professional experience in epidemiological surveillance, community based, participatory research, clinic-based research, mixed methods design and analysis, intervention implementation, program evaluation and health leadership development in the U.S. and the Latin America and Caribbean region including work for the U.S. Centers for Disease Control and Prevention and the World Health Organization.

  • Rong Wang

    Research Scientist

    Research Interests
    Chronic Disease; Epidemiology; Neoplasms; Health Care

    Dr. Wang is a cancer epidemiologist who studies the health outcomes and etiology of different types of cancers, especially hematopoietic malignancies.  She is interested in the pattern of care, treatment and cost in older adults. She is also working on traffic exposure and genetic characteristics on the risk of cancer.


  • Vincent DeVita

    Amy and Joseph Perella Professor of Medicine (Medical Oncology) and Professor of Epidemiology (Chronic Diseases)

    Research Interests
    Hodgkin Disease; Lymphoma; Molecular Biology; Health Care

    Dr. Vincent DeVita, the Amy and Joseph Perella Professor of Medicine at the Yale Cancer Center and Professor of Epidemiology and of Public Health, was the Director of the Yale Cancer Center from 1993 to 2003. He spent the early part of his career at the National Cancer Institute (NCI), and in 1980, the President of the United States appointed him director of the NCI and the National Cancer Program, a position he held until 1988. From 1988 until be returned to Yale in 1993, he was Physician-in-Chief and Attending Physician at Memorial Sloan Kettering Cancer Center and a member of the Program of Molecular Pharmacology. Dr. DeVita has earned international recognition for his accomplishments as a pioneer in the field of Oncology. While at the NCI, he developed combination chemotherapy programs curative for Hodgkin's disease and diffuse large cell lymphomas. He developed the four-drug combination, known by the acronym MOPP, which increased the cure rate for patients with advanced Hodgkin's disease from nearly zero to over 70%. In addition, in collaboration with Dr. George Canellos, he developed the combination chemotherapy CMF, which still remains a useful therapy for breast cancer. He earned his Bachelor of Science degree from the College of William and Mary in 1957. He was awarded his M.D. degree with distinction from the George Washington University School of Medicine in 1961. Dr. DeVita is the author or co-author of more than 450 scientific articles. He is one of the three editors of "Cancer: Principles & Practice of Oncology", in its 11th edition, and serves as the Editor-in-Chief of The Cancer Journal. Dr. DeVita, along with his daughter, Elizabeth DeVita-Raeburn wrote a personal memoir entitled "The Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on cancer is Winnable--and How We Can Get There", published in 2015.

  • Gail D'Onofrio

    Professor of Emergency Medicine; Chair, Department of Emergency Medicine

    Research Interests
    Pharmaceutical Preparations; Chemicals and Drugs

    Dr. D’Onofrio is Professor and the Inaugural Chair of the Department of Emergency Medicine at the Yale School of Medicine (2009) and Physician-in Chief of Emergency Services at Yale-New Haven Hospital EDs with an annual census of approximately 180,000 patients. She is boarded in emergency and addiction medicine.  Dr. D’Onofrio has extensive experience as a leader, researcher, mentor and educator, and is internationally known for her work in alcohol and other substance use disorders (SUDs) as well as for her research on gender variations in women with ischemic heart disease.   Her work (JAMA, 2015) demonstrating that ED-initiated buprenorphine increases engagement in addiction treatment for individuals with OUD, has changed clinical practice, receiving multiple science awards, including awards from the Hazelden Betty Ford Foundation and the Clinical Research Forum.  Dr. D’Onofrio has a long track record of mentoring physician scientists in independent research careers. She is the PI of a NIDA K12 establishing the Yale Drug Use, Addiction and HIV Research Scholars (Yale-DAHRS) program, a Mentored Career Development Program with focused training in prevention and treatment of drug use, addiction, and HIV in general medical settings with scholars in Medicine, Emergency Medicine (EM), Pediatrics, Obstetrics and Gynecology, and Pulmonary Critical Care; and she has mentored numerous EM faculty.  She has received multiple awards including Excellence in Mentoring award from the Association for Medical Education and Research in Substance Abuse (AMERSA 2008), Advancing Women in Emergency Medicine award from the Society of Academic Emergency Medicine (SAEM 2016) and the Academy for Women in Academic Emergency Medicine (AWAEM) Outstanding Department Award for the advancement of women (SAEM 2018). Dr. D’Onofrio is a founding Board member of the Board of Addiction Medicine recently recognized by ABMS as a Specialty, Sub-specialty.  An advocate for individuals with SUD, she is one of the architects of Connecticut Governor’s Strategic Plan to Reduce Opioid Deaths, working with multiple agencies regionally and nationally to change policies and introduce interventions to combat the opioid crisis.

  • Evelyn Hsieh Donroe

    Assistant Professor of Medicine (Rheumatology); Assistant Professor of Epidemiology (Chronic Diseases)

    Research Interests
    Education; Epidemiology; Musculoskeletal Diseases; Osteoporosis; Rheumatology; Global Health; Women's Health

    Dr. Hsieh is Assistant Professor of Medicine (Rheumatology) and Epidemiology (Chronic Diseases) at Yale. She enjoys caring for patients and teaching on the medical wards at Yale-New Haven Hospital. Her areas of academic interest include global health and women's health, with a specific focus on integrating biomedical and behavioral research methods to improve outcomes for rheumatic and musculoskeletal disease in countries in economic transition. Current projects focus on mechanisms, epidemiology, and prevention strategies for osteoporosis among individuals with HIV in China, as well as fracture risk among breast cancer survivors and patients with rheumatoid arthritis. She also has an interest in medical education.

    Dr. Hsieh's research is supported by an International Research Scientist Development Award from the NIH/Fogarty International Center. She has also received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the Doris Duke Foundation, and the Rheumatology Research Foundation. She is honored to be a 2018-19 U.S.-China Fulbright Scholar and to serve on the Board of Directors of the American College of Rheumatology.

  • Charles Fuchs

    Richard Sackler and Jonathan Sackler Professor of Medicine (Medical Oncology); Director, Yale Cancer Center and Physician-in-Chief, Smilow Cancer Hospital

    Charles S. Fuchs, MD, MPH, became Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017. An internationally recognized expert in gastrointestinal cancers and cancer epidemiology, Dr. Fuchs was previously professor of medicine at Harvard Medical School and chief of the gastrointestinal oncology division and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute.

    Dr. Fuchs received his medical degree from Harvard Medical School in 1986. He completed his medical residency at Brigham and Women’s Hospital, where he also served as chief medical resident, and completed his medical oncology fellowship at Dana-Farber Cancer Institute. In 1994, he received his M.P.H. from Harvard School of Public Health. He serves on the Board of Directors for CytomX Therapeutics.

  • Thomas M. Gill

    Humana Foundation Professor of Medicine (Geriatrics) and Professor of Epidemiology (Chronic Diseases) and of Investigative Medicine; Director, Yale Program on Aging; Director, Claude D. Pepper Older Americans Independence Center; Director, Yale Center for Disability and Disabling Disorders; Director, Yale Training Program in Geriatric Clinical Epidemiology and Aging-Related Research

    Research Interests
    Aging; Disability Evaluation; Epidemiology; Geriatrics; Geriatric Assessment; Clinical Trial

    Dr. Thomas Gill is Professor of Medicine, Epidemiology, and Investigative Medicine and the Humana Foundation Professor of Geriatric Medicine at Yale University. He received his research training in clinical epidemiology as a Robert Wood Johnson (RWJ) Clinical Scholar at Yale, and he joined the faculty in 1994 after completing an additional year as a geriatrics fellow. Dr. Gill is a leading authority on the epidemiology and prevention of disability among older persons and is the recipient of numerous awards, including the Paul Beeson Physician Faculty Scholars in Aging Research Award, the RWJ Generalist Physician Faculty Scholar Award, the 2001 Outstanding Scientific Achievement for Clinical Investigation Award from the American Geriatrics Society, the Ewald W. Busse Research Award in the Biomedical Sciences, and the 2012 Joseph T. Freeman Award from the Gerontological Society of America. Dr. Gill holds several leadership positions at Yale, including Director of the Program on Aging and Claude D. Pepper Older Americans Independence Center, Director of the Center on Disability and Disabling Disorders, and Director of an NIA-funded postdoctoral training program in Geriatric Clinical Epidemiology and Aging-Related Research. Dr. Gill’s research and mentoring program is currently supported by an NIA Leadership Award and an NIA-funded R01, and he is a multiple PI for STRIDE, the largest fall injury prevention trial to date. His research accomplishments have been recognized through receipt of a MERIT Award from the National Institutes of Health and election to the American Society of Clinical Investigation and Association of American Physicians.

  • Cary Gross

    Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases); Director, National Clinician Scholars Program at Yale

    Research Interests
    Chronic Disease; Epidemiology; Health Policy; Internal Medicine; Ethics, Research

    Dr. Cary Gross is a Professor of Medicine, and Director of the National Clinician Scholars Program at Yale. Dr. Gross completed his residency in Internal Medicine at New York Hospital-Cornell Medical Center and served as chief medical resident at Memorial Sloan-Kettering Cancer Center the following year.His research addresses comparative effectiveness, quality, and population health, with a focus on cancer prevention and treatment. He is a founding Director of Yale’s Cancer Outcomes Public Policy and Effectiveness Research Center (COPPER). His research has been supported by the National Cancer Institute, the Agency for Healthcare Research and Quality, and the American Cancer Society, among others. As a former Robert Wood Johnson Foundation Clinical Scholar, Dr. Gross has advanced training in biostatistics, epidemiology, research ethics, and outcomes research.

  • Morgan Levine

    Assistant Professor of Pathology

    Research Interests
    Aging; Algorithms; Demography; Epidemiology; Life Expectancy; Longevity; Genetic Variation; Proportional Hazards Models; DNA Methylation; Computational Biology; Gene Expression Profiling; Gene Regulatory Networks; Biostatistics

    Morgan Levine is a ladder-rank Assistant Professor in the Department of Pathology at the Yale School of Medicine and a member of both the Yale Combined Program in Computational Biology and Bioinformatics, and the Yale Center for Research on Aging. Her work relies on an interdisciplinary approach, integrating theories and methods from statistical genetics, computational biology, and mathematical demography to develop biomarkers of aging for humans and animal models using high-dimensional omics data. As PI or co-Investigator on multiple NIH-, Foundation-, and University-funded projects, she has extensive experience using systems-level and machine learning approaches to track epigenetic, transcriptomic, and proteomic changes with aging and incorporate this information to develop measures of risk stratification for major chronic diseases, such as cancer and Alzheimer’s disease. Her work also involves development of systems-level outcome measures of aging, aimed at facilitating evaluation for Geroprotective Interventions. A number of the existing biological aging measures she has developed are being applied in both basic and observational research. Finally, her lab is also involved in a number of collaborations to examine shared molecular signatures in normal aging and cancer.

  • Elan Louis

    Professor of Neurology and of Epidemiology (Chronic Diseases); Chief, Division of Movement Disorders; Co-director, Center for Neuroepidemiology and Clinical Neurological Research

    Research Interests
    Central Nervous System Diseases; Environment and Public Health; Humanities; Disorders of Environmental Origin; Nervous System Diseases; Neurologic Manifestations; Neurodegenerative Diseases; Neurotoxicity Syndromes

    A graduate of University of Pennsylvania (BA, 1984), Yale Medical School (MD, 1989), and Columbia University School of Public Health (MS, Epidemiology, 1995), Dr. Louis joined the College of Physicians and Surgeons, Columbia University faculty in 1995 and was for many years a Professor of Neurology and Epidemiology before being recruited to Yale University in 2015 to be Chief of the Movement Disorders Division in the Department of Neurology. Dr. Louis’ principal academic interest is in degenerative diseases of the central nervous system, focusing on disorders of involuntary movement. He has a particular interest in essential tremor (ET), one of the most common neurological disorders, and his research efforts have focused on a broad spectrum of issues including its epidemiology, genetics, and underlying pathology. His work on ET has been cited in the New York Times as “pioneering” and he is considered to be the leading ET scholar in the world. Through his research, Dr. Louis has challenged many of the prevailing notions about ET and has substantially re-created the dialogue in the ET field. Dr. Louis established and currently leads the Essential Tremor Centralized Brain Repository, which is a national centralized brain bank for the study of ET, and has established a large DNA bank for patients with the disorder. He collaborates with investigators in Spain, Turkey, and Mexico examining the epidemiology of ET in these populations. He has received continuous funding from the National Institutes of Health (NIH) since 1995, as well as funding from the International Essential Tremor Foundation, the Charles A. Dana Foundation, the Parkinson's Disease Foundation, and a Paul Beeson Physician Faculty Scholars Award from the American Federation for Aging Research. He serves on the medical advisory board of the International Essential Tremor Foundation, the Tremor Action Network, and HopeNET. Dr. Louis is the author of over 600 peer-reviewed scientific publications and book chapters and has been invited to write editorials and reviews for Annals of Neurology, New England Journal of Medicine, and Lancet Neurology. He serves on the editorial board of more than ten scholarly peer-reviewed scientific journals and is the founding Editor-in-Chief of the peer-reviewed journal Tremor and Other Hyperkinetic Movements. He is also the current editor of Merritt’s Textbook of Neurology (13th Edition), the most longstanding textbook in the field of neurology. Dr. Louis is committed to the care of his patients with involuntary movements and he has been listed by Castle Connolly as one of the Top Doctors in the field of Neurology.

  • Marcella Nunez-Smith

    Associate Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases); Director, Equity Research and Innovation Center; Director, Center for Research Engagement; Core Faculty, National Clinician Scholars Program; Deputy Director of Health Equity Research and Workforce Development, Yale Center for Clinical Investigation; Director, Yale-Commonwealth Fund Fellowship

    Research Interests
    Chronic Disease; Internal Medicine; Global Health; Women's Health; Caribbean Region; Healthcare Disparities; Social Discrimination

    Dr. Nunez-Smith, MD, MHS, is an Associate Professor at the Yale School of Medicine, Associate Professor at the Yale School of Public Health, Director of the Equity Research and Innovation Center, Director of the Center for Research Engagement, Core Faculty in the National Clinician Scholars Program, and Deputy Director at the Yale Center for Clinical Investigation. Dr. Nunez-Smith’s research focuses on promoting healthcare equity for vulnerable populations with an emphasis on healthcare workforce development, patient assessment of healthcare experiences, and healthcare system strengthening to address chronic disease in low and middle resource settings. She is the principal investigator on several NIH and foundation-funded research projects, including an NIH-fund project to develop a tool to assess patient reported experiences of discrimination in healthcare. In 2011 she received NIH funding to establish the Eastern Caribbean Health Outcomes and Research Network (ECHORN), a research collaborative across four Eastern Caribbean islands that will recruit and follow a community-dwelling adult cohort to examine chronic disease burden and to enhance health outcomes research and leadership capacity in the region. Dr. Nunez-Smith has received numerous awards including the Association of American Medical College’s Herbert W. Nicken’s Faculty Fellowship in 2008 in recognition of her contributions to healthcare workforce diversity and healthcare equity research and a 2011 American Medical Student Association’s Women Leaders in Medicine award. Dr. Nunez-Smith has a BA from Swarthmore College, an MD from Jefferson Medical College, and an MHS from Yale University.

    YCCI Scholar 2006

    Project: 03/01/07 - 08/31/08

    Development of an instrument to measure self-reported experiences of discrimination in health care systems

  • Peter Salovey

    President and Chris Argyris Professor of Psychology; President of the University

    Research Interests
    Behavior and Behavior Mechanisms; Emotions; Psychological Phenomena; Psychology, Applied; Psychology, Social; Health Behavior; Risk Reduction Behavior; Emotional Intelligence; Health Communication; Psychiatry and Psychology

    Peter Salovey is the 23rd president of Yale University, the Chris Argyris Professor of Psychology, and professor of Epidemiology and Public Health, where his research on health behavior has focused on the effectiveness of health promotion messages in persuading people to change risky behaviors relevant to cancer and HIV/AIDS. His presidential term began in July 2013.

    To read his full biography, please visit

  • Mary Tinetti

    Gladys Phillips Crofoot Professor of Medicine (Geriatrics) and Professor in the Institution for Social and Policy Studies; Section Chief, Geriatrics

    Research Interests
    Accidental Falls; Decision Making; Geriatrics; Risk Factors

    Dr. Tinetti is a Professor of Medicine and Public Health and is Chief of Geriatrics at Yale School of Medicine. She is a leading expert in the area of falls and fall injury risk factors identification and prevention. Her current research focus is on clinical decision-making for older adults in the face of multiple health conditions, measuring the net benefit and harms of commonly used medications, and the importance of cross-disease universal health outcomes. She is leading a national effort to develop and test an approach to health care that realigns primary and specialty care to focus on the health priorities of older adults with multiple conditions. She also chairs a group of advisors helping large health systems be Age-Friendly. Dr. Tinetti’s work is funded by the NIH and several foundations. She has published over 200 original peer reviewed articles.  She has served on several national advisory committees including the FDA, NCQA, NQF. Dr. Tinetti has received numerous awards and is a member of the National Academy of Medicine and is the recipient of a MacArthur Foundation fellowship.

  • Kimberly Yonkers

    Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Sciences; Director, Division of Psychological Medicine; Director, Center for Wellbeing of Women and Mothers

    Research Interests
    Anxiety Disorders; Health Care Quality, Access, and Evaluation; Mood Disorders; Substance-Related Disorders; Sexual and Gender Disorders

    I am a Professor in the Departments of Psychiatry, Obstetrics, Gynecology and Reproductive Sciences and in the School of Public Health .  My clinical position is Chief for the Yale New Haven Health Division of Psychological Medicine.  This Division provides inpatient and outpatient consultations to providers and patients in the other medical and surgical divisions of Yale New Haven Health.  Our services are provided at both the York Street and St. Raphael campuses. 

    My research hats include and being Director of Research for the Yale New Haven Hospital Division of the Department of Psychiatry and Director of the Center for Women and Mothers, a research unit in the Department of Psychiatry.  My group investigates the clinical course, etiopathology and treatment of psychiatric and substance use disorders as they occur in women. A major component of this work is the occurrence and treatment of illnesses in pregnancy and the postpartum period, and across the menstrual cycle. This area, by its nature, cuts across disciplines and requires psychiatric expertise, as well as knowledge in neuroscience and reproductive biology. Contributions to the literature include evaluations of the impact of psychiatric conditions and treatments on various birth outcomes.  My group published pivotal work in postpartum depression including the fact that 50% of instances of postpartum depression began antenatally and that standard antidepressant treatment is effective for postpartum onset of major depressive episodes.  My work on premenstrual dysphoric disorder, the severe form of premenstrual syndrome, established the efficacy of serotonin reuptake inhibitors as first line treatments.  Moreover, my work showed that treatment with these agents could commence either halfway through the menstrual cycle or at symptom onset. My recent work has explored the impact and treatment of substance use disorders on pregnancy and pregnancy outcomes.  We devised a screening measure for substance use in pregnancy, the Substance Use Risk Profile-Pregnancy, which is an efficient measure to help identify and assist pregnant women with substance misuse. Additional work in this arena includes finding a therapeutic effect on abstinence of progesterone for women who have postpartum cocaine use, and showing the efficacy of a computerized brief interview, based upon motivational principles, in reducing substance misuse in pregnant and non-pregnant women.

    I led the DSM 5  Study Group for Race, Gender and Ethnicity.  This group assessed psychiatric conditions to determine possible bias in race, gender and ethnicity and incorporated relative text about race, gender and ethnicity into the DSM 5 text.  I currently lead the Gender Study Group that is reviewing and conducting text revisions for the DSM 5 Text Revision.

    I am the inaugural Editor in Chief for a new American Psychiatric Association on-line journal, Psychiatric Research and Clinical Practice. This journal seeks to publish clinical and translational research as well as timely reviews in psychiatry.

Voluntary & Adjunct

  • Anne Marie Jukic
    Research Interests
    Infertility, Female; Pregnancy; Reproduction; Vitamin D

    Dr. Anne Marie Jukic is a perinatal epidemiologist whose research spans the perinatal period, from pre-conception, to pregnancy, to pregnancy outcomes and child health. She is interested in early pregnancy, particularly implantation and early placental development, and the relevance of these events for pregnancy health or child health. Her current research focuses on the role of vitamin D in reproduction, and she has published the first papers describing a link between vitamin D and menstrual cycle function in community-based samples of women. Her other work includes investigating environmental exposures (such as phthalates and phenols), other nutritional exposures, and physical activity. After completing a Bachelor's degree at the University of Notre Dame she joined the Peace Corps where she developed an interest in public health. During her graduate work at Emory University she trained at the Centers for Disease Control in the Safe Motherhood Branch. She continued her graduate studies at the University of North Carolina at Chapel Hill where she completed her doctoral dissertation examining physical activity during pregnancy and pregnancy outcomes. She completed a post-doctoral fellowship at the National Institute for Environmental Health Sciences (NIEHS).

  • Rock G. Positano

    Associate Clinical Professor, Chronic Disease Epidemiology

    Dr. Rock G. Positano is the Founder and Director of the Non-Surgical Foot and Ankle Service and Joe DiMaggio Sports Medicine Center at the Hospital for Special Surgery (HSS) and New York-Presbyterian Hospital/Weill Cornell Medical College in New York City, where he has been on staff since 1991. 

    He is internationally known for his non-surgical approach for the treatment of foot and ankle disorders and developing treatment protocols that prevent the progression of foot and ankle deformities using conservative treatment regimens such as prescription foot orthoses and physical therapy modalities. Most often these non-surgical regimens prevent the need for surgical intervention in the active patient.

    In addition, Dr. Positano's Center at Hospital for Special Surgery in New York City also focuses on the effect that abnormal foot function has on the development of knee, hip and lower back disorders in the active and athletic population.

    Dr. Positano was featured on the front page of the New York Times in an article concerning the dangers of cosmetic foot surgery. He has authored and edited numerous peer reviewed articles and has served as the editor of 11 orthopedic/medical/podiatric textbooks ranging from non- surgical foot and ankle orthopedics, heel disorders, sports medicine, foot and ankle disorder prevention and systemic disease manifestations in the foot, ankle and lower extremity.

  • Douglas Shenson

    Associate Clinical Professor; Associate Professor Adjunct, Department of Medicine, General Medicine Section

    Research Interests
    Humanities; Diseases; Anthropology, Education, Sociology and Social Phenomena; Health Care

    Dr. Shenson is Associate Professor Adjunct, Yale School of Medicine, and Associate Clinical Professor, Yale School of Public Health. He is also Associate Director, Clinical Preventive Services, at the Yale-Griffin Prevention Research Center. Dr. Shenson directs Sickness Prevention Achieved through Regional Collaboration (SPARC), a nonprofit agency dedicated to expanding the population-wide use of disease prevention services. As part of his work at SPARC, Dr. Shenson leads the Vote & Vax program, which is developing and testing a national strategy to provide influenza vaccinations at polling places. Dr. Shenson has led numerous research projects funded by the Centers for Disease Control and Prevention (CDC) to better characterize the provision of vaccinations and cancer screening to older Americans. He is a co-founder of the medical humanitarian organization, Doctors of the World USA (now HealthRight International), and founder of the Human Rights Clinic at Montefiore Medical Center, the first clinic in New York City to attend exclusively to the documentation and service needs of survivors of torture. He is a board member of the International Association for Indigenous Aging (IA2), which focuses on health issues of concern to elder American Indians. Between 2007 and 2016, Dr. Shenson was Course Director of Principles of Epidemiology and Public Health, at Yale School of Medicine (YSM). He currently directs the required Epidemiology, Public Health & Biostatistics Thread, which runs throughout the 18-month YSM pre-clinical curriculum, and he co-leads the YSM/YU Colloquium in History of Medicine and Public Health.

  • Archana Shrestha

    Assistant Professor Adjunct

    Laura Forastiere is an Adjunct Professor in the Department of Chronic Diseases Epidemiology at Yale School of Public Health.

  • Dr. Stolzenberg-Solomon is a Senior Investigator in the Metabolic Epidemiology Branch in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, National Institutes of Health. Dr. Stolzenberg-Solomon received a B.S. in nutrition and dietetics at the University of California, Davis in 1984, followed by a dietetic internship and M.Ed. in health science (nutrition) education at Vanderbilt University Medical Center and George Peabody School of Education, respectively. After this training, she worked as a registered dietitian for several years. In 1994, she completed a M.P.H. with concentrations in epidemiology and nutrition at the Johns Hopkins Bloomberg School of Public Health. Dr. Stolzenberg-Solomon joined the National Cancer Institute in 1996 as a predoctoral fellow in the Cancer Prevention Studies Branch in the in the former Division of Cancer Prevention and Control and later the Center for Cancer Research, and subsequently earned a Ph.D. in epidemiology from the Johns Hopkins Bloomberg School of Public Health in 1999. As a Cancer Prevention Fellow, she continued postdoctoral research in the Division of Cancer Prevention and Division of Cancer Epidemiology and Genetics. She became an investigator in the Nutritional Epidemiology Branch in December 2002, and was awarded NIH scientific tenure and promoted to Senior Investigator in 2011.

    Dr. Stolzenberg-Solomon has won several awards in recognition of her contributions to cancer research, including the 2008 NIH Merit Award for sustained and innovative work in elucidating nutritional, genetic, infectious, and other determinants of pancreatic cancer. She is an active mentor, working with graduate students, as well as postdoctoral fellows. She serves on the editorial board of the American Journal of Epidemiology and Cancer Epidemiology, Biomarkers, and Prevention. Dr. Stolzenberg-Solomon also holds a position as an adjunct Associate Professor at the Yale University School of Public Health, is a fellow of the American College of Epidemiology, and a member of the American Society of Epidemiology.

  • Yetsa Tuakli-Wosornu

    Yetsa A. Tuakli-Wosornu, MD, MPH is a board-certified physical medicine and rehabilitation (PM&R) physician, also known as a physiatrist. A physiatrist focuses on treating problems with the muscles, joints and nerves without surgery.

    Dr. Tuakli-Wosornu specializes in interventional spine and sports medicine treatments, helping people achieve high physical and athletic performance at all stages of life through “holistic mind-body development” and therapies. She approaches her work with a sense of compassion and innovation. Physiatry allows “my experiences as a physician, athlete and public health advocate to dovetail,” she says.

     As a PM&R specialist, she is skilled in such innovative treatments as image-guided joint and spine injections, as well as platelet-rich plasma (PRP), a cutting-edge therapy that helps many athletes heal from injuries faster and better. PRP uses a patient’s own blood and platelets, which contain growth factor proteins known to help tissue heal. The physiatrist injects the material directly into the site of injury in a procedure that can be easily performed in the office setting.

    When she works with patients, Dr. Tuakli-Wosornu often draws upon her personal experience as an athlete. She is a long jumper who represented the Ghana National Team until 2016. She also represents Ghana as part of the 8-member International Paralympic Committee medical committee.

     She has also done extensive community work and serves as the International Paralympic Committee’s inaugural welfare officer. She still treats people in her native West Africa, traveling home about twice per year. “There, preventive health remains underdeveloped, interventional spine care is absent, and the specialty of physiatry has yet to be developed,” says Dr. Tuakli-Wosornu, noting that she hopes to make an impact wherever she can.

  • Herbert Yu
    Research Interests
    Breast Neoplasms; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Uterine Neoplasms; Molecular Epidemiology; Gene-Environment Interaction

    Dr. Yu is adjunct professor at Yale School of Public Health, Department of Chronic Disease Epidemiology, and a molecular epidemiologist with training in medicine, epidemiology, and clinical biochemistry. Dr. Yu has been involved in cancer research for over 20 years, and has had extensive experience in population-based epidemiologic investigation and patient-based clinical studies. Dr. Yu has conducted numerous epidemiologic and clinical research projects, addressing various issues in cancer research, from etiology to detection, and prognosis to treatment. Dr. Yu is especially experienced in laboratory-based molecular epidemiologic studies, and his research interests include gene-environment interaction in cancer development and progression and lifestyle's impact on epigenetic regulation. Dr. Yu has served on numerous national and international grant review committees, and has been involved in the design, execution and analysis of many epidemiological and clinical studies.


  • Lecturer

    Dr. Bortnichak is global head of the Pharmacoepidemiology and Database Research unit at Merck & Co., Inc. His career in the pharmaceutical industry spans 20 years. Immediately prior to joining Merck, Ed was Vice President, Scientific and Medical Healthcare Relations for Astra Zeneca and, prior to that Scientific Affairs role, he served as the Executive Director of Quantitative Decision Sciences for Astra Zeneca, U.S. Clinical Development. He has also held leadership positions managing Research Integration, Statistics, Epidemiology, Drug Safety and Outcomes Research Departments for Sanofi-Synthelabo, Ciba-Geigy, Berlex Laboratories, Pfizer and Ingenix. Prior to his industry career, he co-directed a community heart health behavior change program in Rhode Island and held a faculty post at Brown University

    Ed did his undergraduate studies at the University of Pennsylvania. He holds a Ph.D. in chronic disease epidemiology from the Yale University Graduate School and a Masters of Public Health (M.P.H.) from the Yale University School of Medicine. His post-doctoral work (also at Yale) was in advanced statistical methods, and he currently holds a faculty position as a lecturer in Epidemiology at Yale. 

  • Amy Darefsky

    Lecturer in Epidemiology (Chronic Diseases)

    Dr. Darefsky received her MPH in biostatistics and PhD in epidemiology from Yale University. She has taught a core epidemiology course and lectured on statistical multivariable survival analyses. Her research has focused primarily on adult brain cancer, including the descriptive epidemiology of glioma, risk factors for glioma incidence and glioblastoma multiforme survival. In addition, she has current research interests in the areas of climate change and health and skin cancer prevention. 

  • Lecturer

    Research Interests
    Alcoholic Intoxication; Disaster Planning; Emergency Medicine; Epidemiology; Mental Health; Public Health; Bioethical Issues; Mass Casualty Incidents

    Dr. Degutis, a native of Chicago, received her Bachelor of Science degree from DePaul University, and her MSN and DrPH from Yale University. She is currently Executive Director of Defense Health Horizons, a program of the Henry M. Jackson Foundation for the Advancement of Military Medicine, that is based at the Uniformed Services University. In addition, she is the Chief Science Officer for The Avielle Foundation, and is a consultant in violence and injury prevention. Currently, she serves on the Board of the Pacific Institue for Research and Evaluation (PIRE), the Society for the Advancement of Violence and Injury Research, and the Advisory Board of the College of Science and Health of DePaul University. Prior to this, she was the Director of the National Center for Injury Prevention and Control at the CDC. At Yale, she was Associate Professor of Emergency Medicine and Public Health and was the Director and Co-PI of the Yale Center for Public Health Preparedness, which designed and implemented education in disaster preparedness, response and recovery. She served as a Robert Wood Johnson Health Policy Fellow in the Office of the late Senator Paul Wellstone (D-MN). She is a Past President of the American Public Health Association (APHA), the oldest and largest public health association in the world. Dr. Degutis, a member of the National Academy of Medicine, has received the Distinguished Career and Public Service Awards from the Injury Control and Emergency Health Services Section of APHA, and was named an Honorary Fellow of the Royal Society for Public Health. Her work has focused on public health, injury and violence, substance abuse and policy, as well as disaster preparedness and mitigation.